After an acquisition of Bayer Animal Health in 2020, Elanco has made progress in paying down debt. Robust pipeline with six potential blockbuster products to be launched in 2024 and 2025. Improving ...
Düsseldorf (Reuters) - Der Leverkusener Bayer-Konzern hat sich von einem Teil seiner Aktien des US-Tiergesundheitsunternehmen Elanco Animal Health getrennt. 54,5 Millionen Elanco-Aktien seien am ...
Elanco Animal Health completed a big acquisition of Bayer Animal Health last year, and investors are jumpy about the merger's execution. Second-quarter results exceeded expectations on the top and ...
Elanco Animal Health (ELAN) said it has been granted antitrust clearance by the European Commission to buy Bayer AG’s veterinary health unit after agreeing to divest a number of their products to meet ...
Elanco has closed its $7.6 billion acquisition of Bayer Animal Health. Elanco CEO Jeff Simmons joins Yahoo Finance’s Brian Sozzi and Alexis Christoforous to discuss. ALEXIS CHRISTOFOROUS: All right, ...
BRUSSELS (Reuters) - Elanco Animal Health secured EU antitrust clearance on Monday to buy Bayer's veterinary drugs unit after pledging to sell some products to address competition concerns about the ...
Elanco Animal Health Inc. said Tuesday it is cutting another 380 positions, including about 20% of its senior management, in the latest round of belt-tightening following its $6.9 billion acquisition ...
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced it intends to make concurrent public offerings of 19,159,866 shares of its common stock and 11,000,000 ...
Elanco Animal Health Inc ELAN shares were trading lower Tuesday after the company announced it would acquire Bayer AG BAYRY's animal health business for $5.32 billion in cash and $2.28 billion in ...
Streamlining and simplifying organizational structure to reduce complexity and focus investments in priority areas that drive growth and innovation. Eliminating approximately 380 positions, including ...
Ladies and gentlemen, thank you for standing by, and welcome to the Elanco Animal Health Inc. Q2 2021 Earnings Call. [Operator Instructions] After the speaker presentation, there will be a ...
Elanco Animal Health is making progress on debt repayment, new product approvals, and launches, despite a 20.5% stock decline since August 2024. The stock drop is mainly due to safety risks with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results